Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial

Emmanuelle Le Page, D. Veillard, David Laplaud, Stéphanie Hamonic, R. Wardi, Christine Lebrun‐Frénay, Fabien Zagnoli, Sandrine Wiertlewski, V. Deburghgraeve, Marc Coustans,

The Lancet · 2015 · 175 citations · 20 references

Concepts

References

20